![A liquid biopsy test has detected changes in the BRCA1 or BRCA2 genes associated with ovarian and breast cancer that signal when the disease stops responding to treatment through platinum chemotherapy or poly ADP-ribose polymerase (PARP) inhibitors. [Source: © freshidea/Fotolia]](https://www.clinicalomics.com/wp-content/uploads/2019/01/1322-218x150.jpeg "Ovarian Cancer Blood Test May Eliminate Need for Diagnostic Exploratory Surgery")
![Diagnostic firms are working to create new tests that can detect rheumatoid arthritis earlier and also provide risk assessment profiles of patients that are more or less likely to suffer permanent physical damage as a result of the disease. [©Puwadol Jaturawutthichai/Shutterstock]](https://www.clinicalomics.com/wp-content/uploads/2019/01/169-218x150.jpeg "New Targets Identified For Lupus and Rheumatoid Arthritis")
Seven Bridges to Manage Data for UK Biobank’s WGS Vanguard Phase
Bioinformatics company Seven Bridges, announced it has been selected by the UK Biobank to process and analyze the full genomes of 50,000 volunteers that...
Call to Action
Vural Özdemir, M.D., Ph.D., is editor-in-chief of OMICS: A Journal of Integrative Biology, published by Mary Ann Liebert, Inc. He is also an associate...
![Owlstone Medical's Breath Biospsy platform services will be used by AstraZeneca to identify novel biomarkers differentiating between disease phenotypes for asthma and COPD. [Owlstone Medical]](https://www.clinicalomics.com/wp-content/uploads/2019/01/1594-218x150.jpeg "AstraZeneca to ID Asthma, COPD Biomarkers Using Owlstone Medical’s Breath Biopsy")
AstraZeneca to ID Asthma, COPD Biomarkers Using Owlstone Medical’s Breath Biopsy
Breath Biopsy is designed to help stratify patients by offering a rapid, non-invasive approach to identifying breath-based biomarkers.
New Research Will Probe Relationship between Colorectal Cancer and Colon Microbiota
Colorectal Cancer Alliance provides $125K of funding to Georgetown Lombardi Comprehensive Cancer Center with an emphasis on young-onset CRC
Watson Health, Broad Institute Partner to Tackle Cancer Drug Resistance
The $50 million, five-year collaboration seeks to shed new light on why some tumors develop drug resistance over time, while others do not.
Cancer Genetics Buys Gentris for Up to $6.25M
Cancer Genetics (CGI) said today it plans to acquire Gentris, in an up-to-$6.25 million deal that the buyer said will significantly expand its client...
SkylineDx, Mayo Clinic Collaborate on Melanoma Diagnostics
Bioinformatics specialist SkylineDx will help refine Mayo's algorithm that identifies risk factors associated with melanoma metastasis
Meat of Antibiotic Resistance Is Not in the Meat
Antimicrobial resistance courses to and from livestock via environment, not just antibiotic use.
Snapshot: Noninvasive Prenatal Screening—Making the Case for Responsible Innovation in Genetic Testing
In the dozen years since the sequencing of the human genome, the pace of innovation in genetic testing has exploded. We are now able...
Assessing the Assessments of Cancer Bioinformatics
New computational biology research from Johns Hopkins could lead to more precise ways to target tumor growth.
